Eun Kee Chung

712 total citations
15 papers, 454 citations indexed

About

Eun Kee Chung is a scholar working on Psychiatry and Mental health, Social Psychology and Pharmacology. According to data from OpenAlex, Eun Kee Chung has authored 15 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 4 papers in Social Psychology and 3 papers in Pharmacology. Recurrent topics in Eun Kee Chung's work include Schizophrenia research and treatment (10 papers), Mental Health Treatment and Access (4 papers) and Bipolar Disorder and Treatment (4 papers). Eun Kee Chung is often cited by papers focused on Schizophrenia research and treatment (10 papers), Mental Health Treatment and Access (4 papers) and Bipolar Disorder and Treatment (4 papers). Eun Kee Chung collaborates with scholars based in South Korea, Singapore and Japan. Eun Kee Chung's co-authors include Chay Hoon Tan, Naotaka Shinfuku, Senta Fujii, Kang Sim, Tianmei Si, Shuyu Yang, Mian‐Yoon Chong, Hin‐Yeung Tsang, Chee H. Ng and Yiong Huak Chan and has published in prestigious journals such as American Journal of Psychiatry, The Journal of Nervous and Mental Disease and British Journal of Clinical Pharmacology.

In The Last Decade

Eun Kee Chung

14 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eun Kee Chung South Korea 11 347 107 88 87 80 15 454
Nael Kilzieh United States 10 414 1.2× 168 1.6× 54 0.6× 52 0.6× 87 1.1× 16 561
Susan N. Legacy United States 8 377 1.1× 101 0.9× 94 1.1× 114 1.3× 50 0.6× 9 495
Corina Young United Kingdom 9 530 1.5× 102 1.0× 154 1.8× 41 0.5× 84 1.1× 11 630
Hans Rittmannsberger Austria 13 341 1.0× 158 1.5× 61 0.7× 112 1.3× 58 0.7× 57 591
Michael D. Teehan Canada 12 312 0.9× 119 1.1× 68 0.8× 41 0.5× 87 1.1× 22 526
Judy Hope Australia 10 286 0.8× 108 1.0× 50 0.6× 81 0.9× 85 1.1× 36 454
Yasuo Fujii Japan 11 326 0.9× 118 1.1× 48 0.5× 39 0.4× 53 0.7× 26 468
Shubhra Mace United Kingdom 9 277 0.8× 93 0.9× 55 0.6× 33 0.4× 125 1.6× 14 467
Maila Majak Sweden 6 581 1.7× 176 1.6× 172 2.0× 91 1.0× 77 1.0× 8 734
Mallik Greene United States 11 455 1.3× 92 0.9× 64 0.7× 66 0.8× 70 0.9× 49 563

Countries citing papers authored by Eun Kee Chung

Since Specialization
Citations

This map shows the geographic impact of Eun Kee Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eun Kee Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eun Kee Chung more than expected).

Fields of papers citing papers by Eun Kee Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eun Kee Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eun Kee Chung. The network helps show where Eun Kee Chung may publish in the future.

Co-authorship network of co-authors of Eun Kee Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Eun Kee Chung. A scholar is included among the top collaborators of Eun Kee Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eun Kee Chung. Eun Kee Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Xiang, Yu‐Tao, Chuanyue Wang, Tianmei Si, et al.. (2010). Sex Differences in Use of Psychotropic Drugs and Drug-Induced Side Effects in Schizophrenia Patients: Findings of the Research on Asia Psychotropic Prescription (REAP) Studies. Australian & New Zealand Journal of Psychiatry. 45(3). 193–198. 18 indexed citations
2.
3.
Chong, Mian‐Yoon, Chay Hoon Tan, Naotaka Shinfuku, et al.. (2010). Prescribing antipsychotic drugs for inpatients with schizophrenia in Asia: Comparison of REAP‐2001 and REAP‐2004 studies. Asia-Pacific Psychiatry. 2(2). 77–84. 12 indexed citations
4.
Sim, Kang, Senta Fujii, Shuyu Yang, et al.. (2008). Low doses of antipsychotic drugs for hospitalized schizophrenia patients in East Asia: 2004 vs. 2001. The International Journal of Neuropsychopharmacology. 12(1). 117–117. 6 indexed citations
5.
Sim, Kang, Senta Fujii, Shuyu Yang, et al.. (2008). High‐dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies. British Journal of Clinical Pharmacology. 67(1). 110–117. 43 indexed citations
6.
Kim, Daeho, et al.. (2007). Novelty-Seeking Among Schizophrenia Patients With Comorbid Alcohol Abuse. The Journal of Nervous and Mental Disease. 195(7). 622–624. 17 indexed citations
7.
Sim, Kang, Hong Choon Chua, Rathi Mahendran, et al.. (2006). Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. British Journal of Clinical Pharmacology. 63(4). 431–437. 24 indexed citations
8.
Chung, Eun Kee, et al.. (2005). Alcohol and Aldehyde Dehydrogenase Polymorphisms in Men With Type I and Type II Alcoholism. American Journal of Psychiatry. 162(5). 1003–1005. 19 indexed citations
9.
Cho, Maeng Je, Bong‐Jin Hahm, Eun Kee Chung, et al.. (2004). Korean Epidemiologic Catchment Area(KECA) Study for Psychiatric Disorderscc: Prevalence of Specific Psychiatric Disorders. JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION. 43(4). 470–480. 17 indexed citations
10.
Park, Jong Ik, et al.. (2004). Discrimination of Mentally Ill Persons in Korean Legislative System. JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION. 43(2). 237–241. 2 indexed citations
11.
Sim, Kang, Alex Su, Senta Fujii, et al.. (2004). Depot antipsychotic use in schizophrenia: an East Asian perspective. Human Psychopharmacology Clinical and Experimental. 19(2). 103–109. 31 indexed citations
12.
Sim, Kang, Alex Su, Senta Fujii, et al.. (2004). Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia. British Journal of Clinical Pharmacology. 58(2). 178–183. 111 indexed citations
13.
Chong, Mian‐Yoon, Chay Hoon Tan, Senta Fujii, et al.. (2003). Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change. Psychiatry and Clinical Neurosciences. 58(1). 61–67. 107 indexed citations
14.
Jung, Hee Yeon, et al.. (2002). A Validation Study of Korean-version of Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS): Liverpool University Neuroleptic Side Effect Rating Scale (LUNSERS). 41(1). 138–145. 8 indexed citations
15.
Jiang, Zhengyi, et al.. (1993). Schizophrenic Delusions Among Koreans, Korean-Chinese and Chinese: a Transcultural Study. International Journal of Social Psychiatry. 39(3). 190–199. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026